Your browser doesn't support javascript.
loading
Dysanapsis Genetic Risk Predicts Lung Function Across the Lifespan.
Debban, Catherine L; Ambalavanan, Amirthagowri; Ghosh, Auyon; Li, Zhonglin; Buschur, Kristina L; Ma, Yanlin; George, Elizabeth; Pistenmaa, Carrie; Bertoni, Alain G; Oelsner, Elizabeth C; Michos, Erin D; Moraes, Theo J; Jacobs, David R; Christenson, Stephanie; Bhatt, Surya P; Kaner, Robert J; Simons, Elinor; Turvey, Stuart E; Vameghestahbanati, Motahareh; Engert, James C; Kirby, Miranda; Bourbeau, Jean; Tan, Wan C; Gabriel, Stacey B; Gupta, Namrata; Woodruff, Prescott G; Subbarao, Padmaja; Ortega, Victor E; Bleecker, Eugene R; Meyers, Deborah A; Rich, Stephen S; Hoffman, Eric A; Barr, R Graham; Cho, Michael H; Bossé, Yohan; Duan, Qingling; Manichaikul, Ani; Smith, Benjamin M.
Afiliación
  • Debban CL; University of Virginia, Center for Public Health Genomics, Charlottesville, Virginia, United States.
  • Ambalavanan A; Queen's University, Kingston, Ontario, Canada.
  • Ghosh A; SUNY Upstate Medical University Hospital, Medicine, Syracuse, New York, United States.
  • Li Z; Université Laval, Quebec City, Quebec, Canada.
  • Buschur KL; University of Pittsburgh, Computational and Systems Biology, Pittsburgh, Pennsylvania, United States.
  • Ma Y; University of Pittsburgh, Joint CMU-Pitt PhD Program in Computational Biology, Pittsburgh, Pennsylvania, United States.
  • George E; Columbia University Medical Center, Division of General Medicine, New York, New York, United States.
  • Pistenmaa C; New York Genome Center, Medicine, New York, New York, United States.
  • Bertoni AG; University of Virginia, Charlottesville, Virginia, United States.
  • Oelsner EC; Queen's University, Department of Biomedical and Molecular Sciences, School of Computing, Kingston, Ontario, Canada.
  • Michos ED; Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Moraes TJ; Wake Forest University, Department of Epidemiology and Prevention, Winston-Salem, North Carolina, United States.
  • Jacobs DR; Columbia University, Medicine, New York, New York, United States.
  • Christenson S; Johns Hopkins University, Medicine, Baltimore, Maryland, United States.
  • Bhatt SP; The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Kaner RJ; University of Toronto, Toronto, Ontario, Canada.
  • Simons E; University of Minnesota, Epidemiology, Minneapolis, Minnesota, United States.
  • Turvey SE; University of California, San Francisco, Pulmonary & Critical Care, San Francisco, California, United States.
  • Vameghestahbanati M; University of Alabama at Birmingham, Pulmonary, Allergy and Critical Care Medicine, Birmingham, Alabama, United States.
  • Engert JC; Weill Cornell Medical College, Pulmonary and Critical Care Medicine; Genetic Medicine, New York, New York, United States.
  • Kirby M; University of Manitoba, Pediatrics & Child Health, Winnipeg, Manitoba, Canada.
  • Bourbeau J; BC Children's Hospital and Child & Family Research Centre, Pediatrics, Vancouver, British Columbia, Canada.
  • Tan WC; McGill University Faculty of Medicine, Experimental Medicine, Montreal, Quebec, Canada.
  • Gabriel SB; McGill University Faculty of Medicine, Montreal, Quebec, Canada.
  • Gupta N; Toronto Metropolitan University, Physics, Toronto, Canada.
  • Woodruff PG; Montreal Chest Institute, CORE, Montreal, Quebec, Canada.
  • Subbarao P; McGill University Health Centre, Montreal, Quebec, Canada.
  • Ortega VE; Providence Heart & Lung Institute, University of British Columbia, St Paul's Hospital, UBC James Hogg Research Centre, Vancouver, British Columbia, Canada.
  • Bleecker ER; Broad Institute, Cambridge, Massachusetts, United States.
  • Meyers DA; Broad Institute, Cambridge, Massachusetts, United States.
  • Rich SS; UCSF, Division of Pulmonary and Critical Care Medicine, Department of Medicine and CVRI, San Francisco, California, United States.
  • Hoffman EA; Hospital for Sick Children, Pediatric Respiratory Medicine, Toronto, Ontario, Canada.
  • Barr RG; Mayo Clinic, Internal Medicine, Division of Respiratory Medicine, Scottsdale, Arizona, United States.
  • Cho MH; The University of Arizona Arizona Health Sciences Center, Division of Genetics, Genomics and Precision Medicine, Tucson, Arizona, United States.
  • Bossé Y; The University of Arizona Health Sciences, Division of Genetics, Genomics and Precision Medicine, Tucson, Arizona, United States.
  • Duan Q; University of Virginia, Center for Public Health Genomics, Charlottesville, Virginia, United States.
  • Manichaikul A; University of Iowa Carver College of Medicine, Radiology, Iowa City, Iowa, United States.
  • Smith BM; Columbia University, New York, New York, United States.
Article en En | MEDLINE | ID: mdl-38935874
ABSTRACT
Rationale Dysanapsis refers to a mismatch between airway tree caliber and lung size arising early in life. Dysanapsis assessed by computed tomography (CT) is evident by early adulthood and associated with chronic obstructive pulmonary disease (COPD) risk later in life. Objective By examining the genetic factors associated with CT-assessed dysanapsis, we aimed to elucidate its molecular underpinnings and physiological significance across the lifespan. Methods We performed a genome-wide association study (GWAS) of CT-assessed dysanapsis in 11,951 adults, including individuals from two population-based and two COPD-enriched studies. We applied colocalization analysis to integrate GWAS and gene expression data from whole blood and lung. Genetic variants associated with dysanapsis were combined into a genetic risk score that was applied to examine association with lung function in children from a population-based birth cohort (n=1,278) and adults from the UK Biobank (n=369,157). Measurements and Main Results CT-assessed dysanapsis was associated with genetic variants from 21 independent signals in 19 gene regions, implicating HHIP, DSP, and NPNT as potential molecular targets based on colocalization of their expression. Higher dysanapsis genetic risk score was associated with obstructive spirometry among 5 year old children and among adults in the 5th, 6th and 7th decades of life. Conclusions CT-assessed dysanapsis is associated with variation in genes previously implicated in lung development and dysanapsis genetic risk is associated with obstructive lung function from early life through older adulthood. Dysanapsis may represent an endo-phenotype link between the genetic variations associated with lung function and COPD.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos